P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Verkoczy, L.
- Beteiligte Personen und Organisationen
-
Diaz, M.
Holl, TM
Ouyang, Y.
Bouton-Verville, H.
Alam, SM
Liao, H.
Kelsoe, G.
Haynes, BF
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P54
- URN
-
urn:nbn:de:1111-201608078754
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Verkoczy, L.
- Diaz, M.
- Holl, TM
- Ouyang, Y.
- Bouton-Verville, H.
- Alam, SM
- Liao, H.
- Kelsoe, G.
- Haynes, BF
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Design clues from functional constraints and broadly neutralizing antibodies
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Identification of a novel broadly neutralizing antibody targeting HIV-1
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Design clues from functional constraints and broadly neutralizing antibodies
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Identification of a novel broadly neutralizing antibody targeting HIV-1
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Design clues from functional constraints and broadly neutralizing antibodies
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Identification of a novel broadly neutralizing antibody targeting HIV-1